2006-October Archives by Thread

• Messages sorted by: [ subject ] [ author ] [ date ]
• More info on this list...

Starting: Sun Oct 1 09:42:05 2006
Ending: Mon Oct 30 16:39:36 2006
Messages: 84

• [Ip-health] Joint IBSA Summit Meeting Joint Declaration: September 13, 2006   Thiru Balasubramaniam
• [Ip-health] IP-Watch: WHO Plans Public Hearing On IP Group By December   IP-Watch
• [Ip-health] SUNS: Countries say, Diplomatic Conference on broadcast treaty premature   Sangeeta
• [Ip-health] PUBPAT News: PUBPAT Challenges Monsanto Patents Being Used to Bankrupt American Farmers   Dan Ravicher
  • [Ip-health] PUBPAT News: PUBPAT Challenges Monsanto Patents Being Used to Bankrupt American Farmers   Jeff Williams
• [Ip-health] Email alert: October issue of the WHO Bulletin   bulletin
• [Ip-health] Indiainfoline: Intellectual property...India pitches for a development agenda   Thiru Balasubramaniam
• [Ip-health] U.S. - Dominican Republic to miss latest date for CAFTA implementation   Judit Rius Sanjuan
• [Ip-health] WIPO: Decisions taken on Development Agenda, patents, broadcasting   Sangeeta
• [Ip-health] =?UTF-8?Q?Public=20Forum=20Debate=20On=20WTO=E2=80=99s=20Future?= =?UTF-8?Q?=20Touches=20On=20IP=20Issues?=   Anne St. Martin
• [Ip-health] Draft Brazilian resolution on access to meds at the human rights council   EIPR
• [Ip-health] (no subject)   Richard Elliott
• [Ip-health] Drug firm's tactics reprimanded   Michelle Childs
• [Ip-health] Pharmaceutical Forum: delivering better information, access, prices   Michelle Childs
• [Ip-health] U.S. to stop seizing Canadian drug imports: WSJ   Riaz K Tayob
• [Ip-health] CBO's new study: R&D in the Pharmaceutical Industry   James Love
• [Ip-health] Data Exclusivity and national interest   Riaz K Tayob
• [Ip-health] Mandelson announces EU bilateral trade drive   Michelle Childs
• [Ip-health] DG Trade: IPR target countries   Michelle Childs
• [Ip-health] Bridges Weekly: WIPO GENERAL ASSEMBLY FINDS WAY FORWARD ON BROADCAST TREATY, DEVELOPMENT AGENDA   Thiru Balasubramaniam
• [Ip-health] IFPMA (case study for APCO Worldwide)   Thiru Balasubramaniam
• [Ip-health] $10 Million Prize Set Up for Speedy DNA Decoding   James Love
• [Ip-health] Ellen 't Hoen and James Love in Managing Intellectual Property (MIP)'s list of "most influential people of 2006"   Thiru Balasubramaniam
• [Ip-health] Agency Agrees to Review Human Stem Cell Patents   Ira Glazer
• [Ip-health] 'Off License' drug that cures blindness costs one percent of most commonly prescribed drug   Ira Glazer
• [Ip-health] REMINDER: CPTech Brown Bag with Kevin Outterson on Oct.10   Benjamin Krohmal
• [Ip-health] Drug firms' lobby tactics revealed   Ira Glazer
  • [Ip-health] industry support for drug reviews   Aidan Hollis
• [Ip-health] New book on Aids   Michelle Childs
• [Ip-health] FW: Oct 16 Event - Do US Free Trade Agreements Limit Access to Medicines?   Asia Russell
• [Ip-health] KEI remarks on accepting the MacArthur Award for Creative and Effective Institutions   James Love
• [Ip-health] U.S. to Stop Seizing Canadian Drug Imports   Judit Rius Sanjuan
• [Ip-health] Fwd: Oct 16 Event - Do US Free Trade Agreements Limit Access to Medicines?   Susan Sell
• [Ip-health] Drug Makers Raise Ad Spending   Joana Ramos
• [Ip-health] How Quiet Moves by a Publisher Sway Billions in Drug Spending   Joana Ramos
• [Ip-health] WSJ: Finalists Are Named for Global Health Fund Post   Thiru Balasubramaniam
• [Ip-health] Herbal Medicine: A pharmacopoeia for Africa   prabhu ram
• [Ip-health] TOMORROW: CPTech Brown Bag with Kevin Outterson   Benjamin Krohmal
• [Ip-health] The Netflix prize   James Love
• [Ip-health] India, TRIPS, TRIPS+, and new paradigms   James Love
• [Ip-health] WARF stem cell patents challenged: Research could get faster and cheaper if the patents are narrowed, some scientists say   James Love
• [Ip-health] drug development blog post on Outterson brown bag   Benjamin Krohmal
• [Ip-health] INFO: Public supports overhaul of European scientific publication system]   Michelle Childs
• [Ip-health] Direct-to-consumer advertising revisited by European commission   Michelle Childs
• [Ip-health] In Antipsychotics, Newer isn't Better   Marc-André Gagnon
• [Ip-health] deCODE sues former employees   James Love
• [Ip-health] Letter to Novartis to DROP THE CASE in India   Sheila.SHETTLE@geneva.msf.org
• [Ip-health] TB Alliance Announces $11.3 Million Grant from Irish Government]   Michelle Childs
• [Ip-health] Mark your agendas: CPTech Brown Bag Lunch: Noah Novogrodsky on Compulsory Licensing   Judit Rius Sanjuan
• [Ip-health] Press release: NGOs demand that Novartis withdraws legal actions in India   reinhard
• [Ip-health] DE in India - A response to James Love   James Love
• [Ip-health] Cato Policy Forum: Pan-African Trade Agreement, Andrew Mitchell 10/20   robert weissman
• [Ip-health] DE in India   ravi srinivas
• [Ip-health] KENNEDY, WAXMAN CALL FOR INVESTIGATION OF U.S. TRADE AGREEMENTSAND INTERNATIONAL HEALTH   James Love
• [Ip-health] Speech on Generic Drugs by FTC Commissioner Leibowitz   James Love
• [Ip-health] WIPO Report on Patent Trends   James Love
• [Ip-health] Reminder: ENGAGE AtM strategy session tonight at Oxfam   Sophia Lafontant
• [Ip-health] TOMORROW: CPTech Brown Bag with Thomas Pogge   Benjamin Krohmal
• [Ip-health] Tough Prescription : Heart Medication,Approved for Blacks Faces Uphill Battle   Joana Ramos
• [Ip-health] U.S. FTA may cost drug industry $1.2 billion   heeseob nam
• [Ip-health] Ex-FDA chief charged with lying about stock activities   Jeff Williams
• [Ip-health] Lamy in the FT on cimpulsory licensing   Ellen T HOEN
• [Ip-health] The Gorlin Group on Lamy's comments in FT   Ellen T HOEN
• [Ip-health] Support Access to University-Developed Medicines -- CALL FOR SIGNATORIES   Caroline Gallant
• [Ip-health] Taking Your Product To Market: Clinical Research and Product Launch for Drugs and Devices   Judit Rius Sanjuan
• [Ip-health] =?WINDOWS-1252?Q?=93Corporate_Power_over_EU_Trade_Policy:_Good_f?= =?WINDOWS-1252?Q?or_Business,_Bad_for_the_World=94?=   Michelle Childs
• [Ip-health] Changes to Drug Patent Rules Will Drive Up Prescription Drug Costs   John R. Fulton
• [Ip-health] NEJM paper on extending exclusivity   Benjamin Krohmal
• [Ip-health] MSF comment in The Lancet: Historic opportunity for WHO to re-assert leadership   James ARKINSTALL
• [Ip-health] Novartis Persists With Challenge To Indian Patent Law Despite Adversity   Joana Ramos
• [Ip-health] drug development blog post on Pogge brown bag   Benjamin Krohmal
• [Ip-health] Obstructive stance on generic drugs for poor   James ARKINSTALL
• [Ip-health] MSF at TB Conf 3 Nov -- XDR-TB: can the R&D pipelines respond to the challenge?   Sheila.SHETTLE@geneva.msf.org
• [Ip-health] [Invite to Oxfam Brown Bag] Leahy Legislation to Ensure Access to University Innovations   Robynn Sturm
• [Ip-health] critique of India's proposed data exclusivity/compensation provision   B.Baker@neu.edu
• [Ip-health] Financial Times: WHO ponders the who question, not what and why   Thiru Balasubramaniam
• [Ip-health] DNDi letter to 13 WHO DG candidates   Thiru Balasubramaniam
• [Ip-health] Prize Fund for African Leadership   Benjamin Krohmal
• [Ip-health] Story on how glaxo marketed a disease   Manon Ress
• [Ip-health] International Health & Development Conference at Stanford   Jennifer Staple
• [Ip-health] IP watch: WHO IP wprking Group consultation 1-15th November   Michelle Childs
• [Ip-health] CPTech Brown Bag Lunch: Noah Novogrodsky on Compulsory Licensing   judit.rius@cptech.org
• [Ip-health] DNDi Special Session on the Essential Health R&D Resolution 59.24 at Global Forum, Mon, 30 Oct: 18h00-19h30   Ann-Marie Sevcsik
• [Ip-health] MSF: The XDR-TB Emergency Will Require New Strategies and New Tools   Sheila.SHETTLE@geneva.msf.org

Last message date: Mon Oct 30 16:39:36 2006
Archived on: Mon Oct 30 16:39:36 2006

• Messages sorted by: [ subject ] [ author ] [ date ]
• More info on this list...